Ogkologos

4396 ΔΗΜΟΣΙΕΥΣΕΙΣ 0 ΣΧΟΛΙΑ

EMA Recommends Extension of Indications for Ibrutinib

Ogkologos - 11 Σεπτεμβρίου, 2025

ESMO Highlights the Importance of Prioritising the Fight Against Cancer in...

Ogkologos - 10 Σεπτεμβρίου, 2025

ESMO Urges EU Policymakers to Protect the Wellbeing of the Oncology...

Ogkologos - 10 Σεπτεμβρίου, 2025

Adding Lenvatinib to Pembrolizumab Does Not Provide Additional Benefit in Patients...

Ogkologos - 10 Σεπτεμβρίου, 2025

ESMO awards its first fellowship to support digital and computational pathology

Ogkologos - 10 Σεπτεμβρίου, 2025

Although Not Improving DFS, Adjuvant Avelumab May Potentially Reduce the Risk...

Ogkologos - 9 Σεπτεμβρίου, 2025

Patients with Early-Onset CRC More Often Diagnosed at Advanced Stage of...

Ogkologos - 8 Σεπτεμβρίου, 2025

A toolkit to address disparities in digitally enabled oncology trials

Ogkologos - 5 Σεπτεμβρίου, 2025

EMA Recommends Granting a Marketing Authorisation for Vimseltinib

Ogkologos - 5 Σεπτεμβρίου, 2025

Exceptional Response to Single-Agent Anti-PD1 Therapy Observed in Patients with Advanced...

Ogkologos - 4 Σεπτεμβρίου, 2025

1...394041...440 Σελίδα 40 από 440

MOST POPULAR

A Summer Poem

20 Αυγούστου, 2021

El cáncer en mi comunidad: Cómo superar las desigualdades en la...

3 Ιανουαρίου, 2023

“Scars are Tattoos with Better Stories”

21 Ιουλίου, 2021

Bullies Make Fun Of Little Girl Over Cancer Scars, Her Mom...

29 Μαΐου, 2019

Φόρτωση περισσοτέρων

EMA Recommends Extension of Indications for Ibrutinib

ESMO Highlights the Importance of Prioritising the Fight Against Cancer in...

ESMO Urges EU Policymakers to Protect the Wellbeing of the Oncology...

Adding Lenvatinib to Pembrolizumab Does Not Provide Additional Benefit in Patients...

ESMO awards its first fellowship to support digital and computational pathology

Although Not Improving DFS, Adjuvant Avelumab May Potentially Reduce the Risk...

Patients with Early-Onset CRC More Often Diagnosed at Advanced Stage of...

A toolkit to address disparities in digitally enabled oncology trials

EMA Recommends Granting a Marketing Authorisation for Vimseltinib

Exceptional Response to Single-Agent Anti-PD1 Therapy Observed in Patients with Advanced...

MOST POPULAR

A Summer Poem

El cáncer en mi comunidad: Cómo superar las desigualdades en la...

“Scars are Tattoos with Better Stories”

Bullies Make Fun Of Little Girl Over Cancer Scars, Her Mom...

HOT NEWS

Identification of Potential Biomarkers for Clinical Benefit Following Dual Neoadjuvant Anti-HER2...

Higher Risk of Invasive Behaviour for Oncogenic Fusions–Driven Paediatric Thyroid Cancers

Speaking for Scotland: What our Scottish Campaigns Ambassadors want in a...

Reducing Cancer’s Global Burden: A Conversation with NCI’s Dr. Satish Gopal

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ